Ocular adnexal lymphoproliferative lesions

Area of Science:

• Ophthalmology
• Hematology
• Oncology

Background:

• Ocular adnexal lymphoproliferative lesions encompass a range of conditions, including reactive lymphoid hyperplasia, atypical lymphoid hyperplasia, and lymphoma.
• Distinguishing between these entities using clinical or radiological methods is currently not feasible.
• Hyperplastic processes can potentially progress to localized or systemic lymphoma, mirroring patterns seen in other mucosa-associated lymphoid tumors.

Purpose of the Study:

• To review the spectrum of ocular adnexal lymphoproliferative lesions.
• To discuss the diagnostic and therapeutic approaches for these complex entities.
• To highlight the challenges in predicting prognosis, particularly for small-cell lymphomas.

Main Methods:

• Review of existing literature on ocular adnexal lymphoproliferative lesions.
• Discussion of pathological classification, immunophenotypic labeling, and molecular genetic analysis.
• Synthesis of diagnostic and treatment strategies.

Main Results:

• Ocular adnexal lymphomas are predominantly small lymphocytic non-Hodgkin's tumors with an indolent course, often confined to the ocular adnexa.
• Intermediate- and high-grade lymphomas are less frequent but exhibit more aggressive behavior.
• Prognosis for patients with small-cell lymphoma in the ocular adnexa remains difficult to predict despite advancements.

Conclusions:

• Accurate differentiation of lymphoproliferative lesions in the ocular adnexa is challenging.
• Understanding the potential for progression from hyperplasia to lymphoma is critical.
• Further research is needed to improve prognostic accuracy for ocular adnexal lymphomas.